ES2160164T3 - Himenialdisina y sus derivados, procedimiento para producir un intermedio para su sintesis, y dicho intermedio. - Google Patents

Himenialdisina y sus derivados, procedimiento para producir un intermedio para su sintesis, y dicho intermedio.

Info

Publication number
ES2160164T3
ES2160164T3 ES95918732T ES95918732T ES2160164T3 ES 2160164 T3 ES2160164 T3 ES 2160164T3 ES 95918732 T ES95918732 T ES 95918732T ES 95918732 T ES95918732 T ES 95918732T ES 2160164 T3 ES2160164 T3 ES 2160164T3
Authority
ES
Spain
Prior art keywords
produce
himenialdisina
synthesis
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918732T
Other languages
English (en)
Inventor
Hirokazu Annoura
Toshio Tatsuoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2160164T3 publication Critical patent/ES2160164T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

HIMENIALDISINA REPRESENTADA POR LA FORMULA GENERAL (I) Y UN DERIVADO DE LA MISMA, Y UN PROCESO PARA PRODUCIR EL MISMO, DONDE X{SUP,1} REPRESENTA HALOGENO O HIDROGENO. ESTOS COMPUESTOS POSEEN UN EFECTO INHIBIDOR DE LA PROTEINA DE QUINASA C Y SE CONSIDERAN UN REMEDIO PARA LAS ENFERMEDADES DONDE LA ACTIVACION DE LA PROTEINA DE QUINASA C JUEGA UN PAPEL.
ES95918732T 1994-05-18 1995-05-17 Himenialdisina y sus derivados, procedimiento para producir un intermedio para su sintesis, y dicho intermedio. Expired - Lifetime ES2160164T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10403094A JP3714685B2 (ja) 1994-05-18 1994-05-18 ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体

Publications (1)

Publication Number Publication Date
ES2160164T3 true ES2160164T3 (es) 2001-11-01

Family

ID=14369852

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918732T Expired - Lifetime ES2160164T3 (es) 1994-05-18 1995-05-17 Himenialdisina y sus derivados, procedimiento para producir un intermedio para su sintesis, y dicho intermedio.

Country Status (9)

Country Link
US (1) US5621099A (es)
EP (1) EP0711773B1 (es)
JP (1) JP3714685B2 (es)
KR (1) KR960703916A (es)
AU (1) AU701436B2 (es)
CA (1) CA2167515A1 (es)
DE (1) DE69522642T2 (es)
ES (1) ES2160164T3 (es)
WO (1) WO1995031462A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159510A1 (en) 1993-04-08 1994-10-27 David A. Horne Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
JP3563076B2 (ja) * 1995-12-01 2004-09-08 第一サントリーファーマ株式会社 ピロロアゼピン誘導体
CA2216559A1 (en) * 1997-09-25 1999-03-25 Michel Roberge G2 checkpoint inhibitors and assay
US6197954B1 (en) 1998-01-30 2001-03-06 The Trustees Of Columbia University In The City Of New York Intermediates for the synthesis of debromohymenialdisine and processes thereof
US6211361B1 (en) * 1999-07-20 2001-04-03 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon, State Univeristy Method for making debromohymenialdisine and analogs thereof
EP1106180B1 (en) * 1999-12-08 2003-11-12 Centre National de la Recherche Scientifique (CNRS) Use of hymenialdisine or derivatives thereof in the manufacture of medicaments
CA2397774A1 (en) * 2000-01-24 2001-07-26 Genzyme Corporation Jak/stat pathway inhibitors and the uses thereof
HUP0302002A3 (en) 2000-05-11 2007-02-28 Consejo Superior Investigacion Heterocyclic inhibitors of glycogen synthase kinase gsk-3, their use and pharmaceutical compositions containing them
AU2003301226A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corp Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
US7423031B2 (en) * 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
WO2004103958A2 (en) * 2003-05-19 2004-12-02 Michigan State University Preparation of hymenialdisine derivatives and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62161786A (ja) * 1986-01-08 1987-07-17 Mitsubishi Chem Ind Ltd ピロ−ル化合物
US4729996A (en) * 1986-05-29 1988-03-08 Harbor Branch Oceanographic Institution, Inc. Antitumor compositions and their methods of use
JP3198117B2 (ja) * 1990-02-07 2001-08-13 サントリー株式会社 ピロロアゼピン誘導体
AU3731293A (en) * 1992-02-24 1993-09-13 Smithkline Beecham Corporation Protein kinase c inhibitor

Also Published As

Publication number Publication date
WO1995031462A1 (fr) 1995-11-23
EP0711773A1 (en) 1996-05-15
EP0711773B1 (en) 2001-09-12
JP3714685B2 (ja) 2005-11-09
AU701436B2 (en) 1999-01-28
AU2454195A (en) 1995-12-05
CA2167515A1 (en) 1995-11-23
US5621099A (en) 1997-04-15
KR960703916A (ko) 1996-08-31
DE69522642T2 (de) 2002-04-18
EP0711773A4 (es) 1996-06-19
DE69522642D1 (de) 2001-10-18
JPH07309874A (ja) 1995-11-28

Similar Documents

Publication Publication Date Title
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
ES2137628T3 (es) Derivados de estilbeno y composiciones farmaceuticas que los contienen.
ES2184127T3 (es) Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
ES2062943B1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
ATE256671T1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate
ES2160164T3 (es) Himenialdisina y sus derivados, procedimiento para producir un intermedio para su sintesis, y dicho intermedio.
DE69531682D1 (de) Sterolderivate für die regulierung der meiose
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
DE69225410D1 (de) Herstellung von n-acetylneuraminsäure-derivaten
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
DK0533790T3 (da) Hidtil ukendt saltform af 5-difluormethoxy-2-((3,4-dimethoxy-2-pyridyl)methylsulfinyl)-1H-benzimidazol
ES2163197T3 (es) Procedimiento para producir ditiobis-alcanosulfonatos y fosfonatos.
ES2193271T3 (es) Procedimiento de preparacion de derivados de fenilimidazolidina.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
NO975028D0 (no) Piperazinoderivater som neurokininantagonister
FI964045A (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
SE9604582D0 (sv) Novel compounds
DE69736180D1 (de) Behandlung von manischen erkrankungen
NO963369L (no) Nye indan-2-mercaptoacetylamid-disulfidderivater som er anvendbare som inhibitorer av enkefalinase
ES2159676T3 (es) Derivados de triazol con actividad antimicotica e intermediarios.
DE69808922D1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711773

Country of ref document: ES